A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups

Medicine (United States)

Volumn 70, Issue 6, 1991, Pages 360-374

  Love, Lori A ^a   Leff, Richard L ^a   Fraser, David D ^a,d   Targoff, Ira N ^b   Dalakas, Marinos ^c   Plotz, Paul H ^a   Miller, Frederick W ^a,e  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

^e CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNITY; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMYOSITIS; PRIORITY JOURNAL;

ADULT; AUTOANTIBODIES; DERMATOMYOSITIS; FEMALE; HLA ANTIGENS; HUMAN; IMMUNOGENETICS; INCLUSION BODIES; MALE; MIDDLE AGE; MYOSITIS; PROGNOSIS;

EID: 0026354417     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/00005792-199111000-00002     Document Type: Article

References (61)

1. Arnett FC, Goldstein R, Duvic M, Reveille JD. Major histocompatibility complex genes in systemic lupus erythematosus, Sjögren's syndrome, and polymyositis. Am J Med 85: 38-41, 1988.
2. Arnett FC, Hirsch TJ, Bias WB, Nishikai M, Reichlin M. The Jo-1 antibody system in myositis: relationships to clinical features and HLA. J Rheumatol 8: 925-30, 1981.
3. Arsura EL, Greenberg AS. Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthritis Rheum 18: 29-37, 1988.
4. Behan WM, Behan PO. Immunological features of polymyositis/dermatomyositis. Springer Semin Immunopathol 8: 267-93, 1985.
5. Benbassat J, Gefel D, Larholt K, Sukenik S, Morgenstern V, Zlotnick A. Prognostic factors in polymyositis/dermatomyositis. A computerassisted analysis of ninety-two cases. Arthritis Rheum 28: 249-55, 1985.
6. Boey ML, Peebles CL, Tsay G, Feng PH, Tan EM. Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis 47: 918-23, 1988.
7. Bohan A, Peter JB. Polymyositis and dermatomyositis (parts 1 and 2). N Engl J Med 292: 344-47, 403-7, 1975.
8. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 56: 255-86, 1977.
9. Boire G, Craft J. Human Ro ribonucleoprotein particles: characterization of native structure and stable association with the La polypeptide. J Clin Invest 85: 1182-90, 1990.
10. Bowles NE, Dubowitz V, Sewry CA, Archard LC. Dermatomyositis, polymyositis, and coxsackie-B-virus infection. Lancet 1: 1004-1007, 1987.
11. Bunn CC, Bernstein RM, Mathews MB. Autoantibodies against alanyl-tRNA synthetase and tRNA(ALA) coexist and are associated with myositis. J Exp Med 163: 1281-91, 1986.
12. Bunn CC, Mathews MB. Autoreactive epitope defined as the anticodon region of alanine transfer RNA. Science 238: 1116-19, 1987.
13. Christensen ML, Pachman LM, Schneiderman R, Patel DC, Friedman JM. Prevalence of coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 29: 1365-70, 1986.
14. Cohen MR, Sulaiman AR, Garancis JC, Wortmann RL. Clinical heterogeneity and treatment response in inclusion body myositis. Arthritis Rheum 32: 734-40, 1989.
15. Cronin ME, Miller FW, Plotz PH. Polymyositis and Dermatomyositis. In: Schumacher HR, Jr, Klippel JH, Robinson DR, eds. Primer on the Rheumatic Diseases. 9th ed. Atlanta, GA: Arthritis Foundation, p. 120, 1988.
16. Cronin ME, Plotz PH, Miller FW. Abnormalities of the immune system in the idiopathic inflammatory myopathies. In Vivo 2: 25-30, 1988.
17. Deegen MA, Walkes SE, Lovell SE. Antibodies to double stranded DNA: A comparison of the indirect immunofluorescent test using Crithidia luciliae and the DNA-binding assay. Am J Clin Pathol 69: 599-610, 1978.
18. Elkon KB, Gharavi AE, Hughes GR, Moutsopoulos HM. Autoantibodies in the sicca syndrome (primary Sjögren's syndrome). Ann Rheum Dis 43: 243-45, 1984.
19. Franks AG. Important cutaneous markers of dermatomyositis. J Musculoskeletal Med 10: 39-63, 1988.
20. Goldstein R, Duvic M, Targoff IN, Reichlin M, McMenemy AM, Reveille JD, Warner NB, Pollack MS, Amett FC. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum 33:1240-48, 1990.
21. Henriksson KG, Sandstedt P. Polymyositis-treatment and prognosis. A study of 107 patients. Acta Neurol Scand 65: 280-300, 1982.
22. Hochberg MC, Feldman D, Stevens MB, Arnett FC, Reichlin M. Antibody to Jo-1 in polymyositis/dermatomyositis: Association with interstitial pulmonary disease. J Rheumatol 11: 663-65, 1984.
23. Hochberg MC, Lopez-Acuna D, Gittelsohn AM. Mortality from polymyositis and dermatomyositis in the United States, 1968-1978. Arthritis Rheum 26:1465-71, 1983.
24. Hoffman GS, Franck WA, Raddatz DA, Stallones L. Presentation, treatment, and prognosis of idiopathic inflammatory muscle disease in a rural hospital. Am J Med 75: 433-38, 1983.
25. Leff RL, Burgess SH, Miller FW, Love LA, Joffe MM, Plotz PH. Distinct seasonal patterns in the onset of myositis in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies (abstract). Clin Research 38: 529A, 1990.
26. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis. Observations in 40 patients. Brain 112: 727-47, 1989.
27. Mathews MB, Bernstein RM. Myositis autoantibody inhibits histidyl-tRNA synthetase: A model for autoimmunity. Nature 304: 177-79, 1983.
28. Mathews MB, Reichlin M, Hughes GR, Bernstein RM. Antithreonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med 160: 420-34, 1984.
29. Mikol J. Inclusion body myositis. In: Engel AG, Banker BO, eds. Myology. New York, NY: McGraw-Hill Book Co., p. 1423, 1986.
30. Miller FW, Cronin ME, Love LA. Increased prevalence of hypothyroidism and its association with pulmonary fibrosis in patients with idiopathic inflammatory myopathy (IIM) (abstract). Arthritis Rheum 30(Suppl): S64, 1987.
31. Miller FW, Love LA, Barbieri SA, Balow JE, Plotz PH. Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups. Clin Exp Immunol 81: 373-79, 1990.
32. Miller FW, Love LA, Leff RL, Fraser DD, Plotz PH. Clinical and autoantibody subgroups predict therapeutic responses and prognosis in the idiopathic inflammatory myopathies (IIM) (abstract). Arthritis Rheum 32(Suppl): S125, 1989.
33. Miller FW, Waite KA, Biswas T, Plotz PH. The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. Proc Natl Acad Sci USA 87: 9933-37, 1990.
34. Moyer RA, Phillips CA, Torretti D, Newman ED. Clinical features and outcome in inflammatory myopathy (abstract). Arthritis Rheum 32(Suppl): S32, 1989.
35. Oddis CV, Medsger TA, Cooperstein LA. A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis. Arthritis Rheum 33:1640-45, 1990.
36. Pearson CM, Bohan A. The spectrum of polymyositis and dermatomyositis. Med Clin North Am 61: 439-57, 1977.
37. Plotz PH. Autoantibodies are anti-idiotype antibodies to antiviral antibodies. Lancet 2: 824-26, 1983.
38. Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME. Current concepts in the idiopathic inflammatory myopathies: Polymyositis, dermatomyositis, and related disorders. Ann Intern Med 111: 143-57, 1989.
39. Pruijn GJ, Slobbe RL, van Venrooij WJ. Structure and function of La and Ro RNPs. Mol Biol Rep 14: 43-48, 1990.
40. Reeves WH, Nigam SK, Blobel G. Human autoantibodies reactive with the signal-recognition particle. Proc Natl Acad Sci USA 83: 9507-11, 1986.
41. Reichlin M, Arnett FC, Jr. Multiplicity of antibodies in myositis sera. Arthritis Rheum 27:1150-56, 1984.
42. Rheins MS, McCoy FW, Burrell RG, Buehler EV. A modification of the latex-fixation test for the study of rheumatoid arthritis. J Lab Clin Med 50:113-18, 1957.
43. Rubin LA, Shi M, Tsui FWL. Anti-Jo-1 binds antigen in the cytoplasm of human myoblasts (abstract). Arthritis Rheum 33(suppl):S74, 1990.
44. SAS User's Guide: Basics, Version 5 Edition. 5th ed. Cary, NC: SAS Institute Inc., 1985.
45. Sawchak JA, Kula RW. Inclusion body myositis. In: Dalakas MC, ed. Polymyositis and Dermatomyositis. Boston: Butterworths, p. 121, 1988.
46. Schumacher HR, Jr, Klippel JH, Robinson DR. Primer on the Rheumatic Diseases. 9th ed. Atlanta, GA: Arthritis Foundation, 1988.
47. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52: 148-59, 1972.
48. Stahl NI, Klippel JH, Decker JL. A cutaneous lesion associated with myositis. Ann Intern Med 91: 577-79, 1979.
49. Targoff IN. New anti-synthetases in polymyositis (abstract). Arthritis Rheum 31(Suppl): S13, 1988.
50. Targoff IN. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two addition synthetases are antigenic in myositis. J Immunol 144: 1737-43, 1990.
51. Targoff IN, Arnett FC. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med 88: 241-51, 1990.
52. Targoff IN, Arnett FC, Berman L, O'Brien C, Reichlin M. Anti-KJ: A new antibody associated with the syndrome of polymyositis and interstitial lung disease. J Clin Invest 84:162-72, 1989.
53. Targoff IN, Arnett FC, Reichlin M. A new antibody associated with myositis and lung disease (abstract). Arthritis Rheum 30(Suppl): S24, 1987.
54. Targoff IN, Arnett FC, Reichlin M. Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum 31: 515-24, 1988.
55. Targoff IN, Hanas J. The polymyositis-associated FER antigen is elongation factor lα (abstract). Arthritis Rheum 32(Suppl): S81, 1989.
56. Targoff IN, Johnson AE, Miller FW. Antibody to signal recognition particle in polymyositis. Arthritis Rheum 33:1361-70, 1990.
57. Targoff IN, Nilasena DS, Trieu EP. Clinical features and immunologic testing of patients with anti-Mi-2 antibodies (abstract). Arthritis Rheum 33(Suppl): S72, 1990.
58. Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 28: 796-803, 1985.
59. Tsokos GC, Moutsopoulos HM, Steinberg AD. Muscle involvement in systemic lupus erythematosus. JAMA 246: 766-68, 1981.
60. Wasicek CA, Reichlin M. Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest 69:835-43, 1982.
61. Witebsky E, Rose NR. Studies on organ specificity IV. Production of rabbit thyroid antibodies in the rabbit. J Immunol 76: 408-16, 1956.